These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 32920586)
1. Granulocyte colony-stimulating factors (G-CSF) and Covid-19: a double-edged sword? Tralongo AC; Danova M Infez Med; 2020 Sep; 28(3):459-460. PubMed ID: 32920586 [TBL] [Abstract][Full Text] [Related]
2. How to face cancer treatment in the COVID-19 era. Brandes AA; Di Nunno V Expert Rev Anticancer Ther; 2020 Jun; 20(6):429-432. PubMed ID: 32370563 [No Abstract] [Full Text] [Related]
3. Double-edged sword: Granulocyte colony stimulating factors in cancer patients during the COVID-19 era. Alkan A; Uncu A; Taşkıran I; Tanrıverdi Ö Clinics (Sao Paulo); 2020; 75():e2033. PubMed ID: 32638908 [No Abstract] [Full Text] [Related]
4. Potential protective and therapeutic role of immune checkpoint inhibitors against viral infections and COVID-19. Gatto L; Franceschi E; Nunno VD; Brandes AA Immunotherapy; 2020 Oct; 12(15):1111-1114. PubMed ID: 32594820 [No Abstract] [Full Text] [Related]
5. Music of microbiota against SARS CoV-2. Belojevic G; Prasher D Noise Health; 2019; 21(100):97. PubMed ID: 32655062 [No Abstract] [Full Text] [Related]
6. Granulocyte-colony stimulating factor in COVID-19: Is it stimulating more than just the bone marrow? Nawar T; Morjaria S; Kaltsas A; Patel D; Perez-Johnston R; Daniyan AF; Mailankody S; Parameswaran R Am J Hematol; 2020 Aug; 95(8):E210-E213. PubMed ID: 32419212 [No Abstract] [Full Text] [Related]
8. Is it fair to hope that patients with Type 1 Diabetes (autoimmune) may be spared by the infection of Covid-19? Tatti P; Tonolo G; Zanfardino A; Iafusco D Med Hypotheses; 2020 Sep; 142():109795. PubMed ID: 32416410 [TBL] [Abstract][Full Text] [Related]
9. What is COVID-19? Pediatr Dermatol; 2020 May; 37(3):555-556. PubMed ID: 32598543 [No Abstract] [Full Text] [Related]
10. Herd immunity and COVID-19. Chen J; Ye L; Zhou MY; Cheng YR; Wang MW; Feng ZH Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4064-4065. PubMed ID: 32374011 [No Abstract] [Full Text] [Related]
11. Is Gradual and Controlled Approach to Herd Protection a Valid Strategy to Curb the COVID-19 Pandemic? Laxminarayan R; John TJ Indian Pediatr; 2020 Jun; 57(6):505-507. PubMed ID: 32376793 [No Abstract] [Full Text] [Related]
13. Use of protective partition during extubation in the COVID-19 pandemic. Bakshi SG; Trivedi B; Patil VP Indian J Cancer; 2020; 57(4):500-501. PubMed ID: 33078764 [No Abstract] [Full Text] [Related]
15. Vaccine Development Against COVID-19 Prior to Pandemic Outbreaks, Using Zayed H Front Immunol; 2020; 11():2051. PubMed ID: 32922408 [No Abstract] [Full Text] [Related]
17. The COVID-19 outbreak: a snapshot from down under. van Zandwijk N; Rasko JEJ Expert Rev Anticancer Ther; 2020 Jun; 20(6):433-436. PubMed ID: 32419533 [No Abstract] [Full Text] [Related]
18. The paramount importance of serological surveys of SARS-CoV-2 infection and immunity. Goudsmit J Eur J Epidemiol; 2020 Apr; 35(4):331-333. PubMed ID: 32318914 [No Abstract] [Full Text] [Related]
19. Developing Covid-19 Vaccines at Pandemic Speed. Lurie N; Saville M; Hatchett R; Halton J N Engl J Med; 2020 May; 382(21):1969-1973. PubMed ID: 32227757 [No Abstract] [Full Text] [Related]
20. The COVID-19 pandemic and the use of MS disease-modifying therapies. Giovannoni G; Hawkes C; Lechner-Scott J; Levy M; Waubant E; Gold J Mult Scler Relat Disord; 2020 Apr; 39():102073. PubMed ID: 32334820 [No Abstract] [Full Text] [Related] [Next] [New Search]